Susquehanna International Group, LLP Icosavax, Inc. Call Options Transaction History

Susquehanna International Group, LLP

  • $527 Billion
  • Q2 2024

Call Options

3 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q2 2023

Aug 11, 2023
BUY
$4.89 - $10.57 $196,089 - $423,857
40,100 New
40,100 $398,000
Q4 2022

Feb 14, 2023
BUY
$2.32 - $10.97 $92,336 - $436,606
39,800 New
39,800 $316,000
Q2 2022

Aug 15, 2022
BUY
$5.7 - $10.33 $58,710 - $106,399
10,300 New
10,300 $59,000

Others Institutions Holding ICVX

# of Institutions
2
Shares Held
1.37M
Call Options Held
0
Put Options Held
0
View Full List

About Icosavax, Inc.

ICVX Quotes by TradingView
  • Ticker ICVX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 39,885,200
  • Description
  • Icosavax, Inc., a biopharmaceutical company, develops vaccines against infectious diseases. The company, with the help of its virus-like particle (VLP) platform technology, focuses primarily on life-threatening respiratory diseases. Its products in pipeline include IVX-121, a vaccine candidate with RSV target and is under Phase 1/1b clinical tri...
More about ICVX
Track This Portfolio

Track Susquehanna International Group, LLP Portfolio

Follow Susquehanna International Group, LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email